We are live on ! Find out more
CM

Crestline Management Portfolio holdings

AUM $46.3M
1-Year Est. Return 48.82%
This Fund
S&P 500
This Quarter Est. Return
-7.09%
1 Year Est. Return
+48.82%
3 Year Est. Return
+52.52%
5 Year Est. Return
+37.91%
10 Year Est. Return
+316.44%
AUM
$952M
AUM Growth
+$148M
Cap. Flow
+$242M
Cap. Flow %
25.41%
Top 10 Hldgs %
41.49%
Holding
321
New
111
Increased
81
Reduced
33
Closed
93

Top Sells

Rank Stock Value
1
V icon
Visa
V
+$14.2M
2
AIZ icon
Assurant
AIZ
+$8.7M
3
PFG icon
Principal Financial Group
PFG
+$8.66M
4
CME icon
CME Group
CME
+$6.58M
5
VOYA icon
Voya Financial
VOYA
+$5.48M

Sector Composition

Rank Sector Weight
1 Healthcare 42.54%
2 Financials 13.82%
3 Technology 12.96%
4 Industrials 10.18%
5 Real Estate 7.26%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MWA icon
176
Mueller Water Products
MWA
$3.95B
$1.31M 0.14%
+111,546
New +$1.25M
RYTM icon
177
Rhythm Pharmaceuticals
RYTM
$6.81B
$1.28M 0.13%
+41,047
New +$1.12M
PRTY
178
DELISTED
Party City Holdco Inc.
PRTY
$1.28M 0.13%
+84,099
New +$1.29M
EFII
179
DELISTED
Electronics for Imaging
EFII
$1.28M 0.13%
39,228
-25,135
-39% -$799K
KALA icon
180
KALA BIO
KALA
$14.1M
$1.26M 0.13%
37
+12
+48% +$460K
PTCT icon
181
PTC Therapeutics
PTCT
$5.64B
$1.25M 0.13%
37,203
-40,426
-52% -$1.26M
STRL icon
182
Sterling Infrastructure
STRL
$18.3B
$1.24M 0.13%
+95,012
New +$1.18M
HIW icon
183
Highwoods Properties
HIW
$3.65B
$1.2M 0.13%
23,576
-19,858
-46% -$915K
POST icon
184
Post Holdings
POST
$4.14B
$1.19M 0.13%
+21,215
New +$1.11M
BDN
185
Brandywine Realty Trust
BDN
$524M
$1.18M 0.12%
70,133
-16,406
-19% -$263K
ESRT icon
186
Empire State Realty Trust
ESRT
$872M
$1.17M 0.12%
68,684
-115,589
-63% -$1.95M
OTIC
187
DELISTED
Otonomy, Inc.
OTIC
$1.15M 0.12%
297,559
BLBD icon
188
Blue Bird Corp
BLBD
$2.35B
$1.1M 0.12%
+49,169
New +$1.08M
FOMX
189
DELISTED
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
$1.09M 0.11%
217,670
HSTO
190
DELISTED
Histogen Inc. Common Stock
HSTO
$1.08M 0.11%
+1,264
New +$1.05M
PBYI icon
191
Puma Biotechnology
PBYI
$404M
$1.07M 0.11%
+18,132
New +$1.05M
SPPI
192
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
$1.04M 0.11%
+49,743
New +$921K
BEL
193
DELISTED
Belmond Ltd.
BEL
$1.04M 0.11%
+93,352
New +$1.07M
BECN
194
DELISTED
Beacon Roofing Supply, Inc.
BECN
$1.02M 0.11%
+23,904
New +$1.1M
LLY icon
195
Eli Lilly
LLY
$1.02T
$1.01M 0.11%
+11,786
New +$968K
DERM
196
DELISTED
Dermira, Inc.
DERM
$981K 0.1%
106,593
-39,192
-27% -$365K
STT icon
197
State Street
STT
$50.6B
$978K 0.1%
+10,508
New +$1.04M
PRGO icon
198
Perrigo
PRGO
$1.4B
$966K 0.1%
+13,244
New +$1.02M
ACCO icon
199
Acco Brands
ACCO
$389M
$956K 0.1%
+69,059
New +$886K
RETA
200
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
$925K 0.1%
26,439
-62,236
-70% -$1.9M

Similar funds

Crestline Management's Q2 2018 Portfolio in Review

As of Q2 2018, Crestline Management held 321 positions worth $952M, up 18% from $804M the previous quarter. Its ten largest holdings account for 41% of the portfolio.

Crestline Management deployed $242M of net new capital in Q2 2018, opening 111 new positions and adding to 81 existing holdings. Its largest new stake was Affiliated Managers Group: 73,871 shares worth $11M.

By sector, the portfolio is most concentrated in Healthcare at 43% of assets, down from 56% a quarter earlier, followed by Financials and Technology.

On the sell side, the largest reduction was Voya Financial, an estimated $5.48M trimmed.

  • Crestline Management's largest Q2 2018 buy was Affiliated Managers Group: 73,871 shares worth $11M.
  • Crestline Management added most to IHS Markit Ltd. Common Shares in Q2 2018, an estimated $8.58M increase.
  • Crestline Management's biggest Q2 2018 reduction was Voya Financial, cutting an estimated $5.48M.
  • Crestline Management fully exited Visa in Q2 2018, selling an estimated $14.2M.
  • Crestline Management's ten largest holdings make up 41% of its $952M portfolio in Q2 2018.
  • Crestline Management opened 111 new positions and closed 93 in Q2 2018.
  • Crestline Management's portfolio value rose 18% quarter-over-quarter to $952M.

Based on Crestline Management's 13F filing for Q2 2018, filed 14 Aug 2018.